Have a feature idea you'd love to see implemented?
Let us know!
NOVT Novanta Inc
Price (delayed)
$176.765
Market cap
$6.35B
P/E Ratio
102.18
Dividend/share
N/A
EPS
$1.73
Enterprise value
$6.78B
Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers ('OEMs') a competitive advantage. Novanta combines deep proprietary technology expertise and
Highlights
The equity has increased by 12% YoY and by 3% from the previous quarter
Novanta's debt has increased by 17% YoY but it has decreased by 6% from the previous quarter
The stock's P/E is 22% more than its last 4 quarters average of 83.9 and 19% more than its 5-year quarterly average of 86.3
The EPS has contracted by 20% YoY and by 10% from the previous quarter
Key stats
What are the main financial stats of NOVT
Market
Valuations
Earnings
Shares outstanding
35.9M
Market cap
$6.35B
Enterprise value
$6.78B
Price to earnings (P/E)
102.18
Price to book (P/B)
9.04
Price to sales (P/S)
7.06
EV/EBIT
66.49
EV/EBITDA
44.62
EV/Sales
7.54
Revenue
$899.85M
EBIT
$101.98M
EBITDA
$151.97M
Free cash flow
$133.26M
Per share
Balance sheet
Liquidity
EPS
$1.73
Free cash flow per share
$3.71
Book value per share
$19.56
Revenue per share
$25.03
TBVPS
$16.82
Total assets
$1.4B
Total liabilities
$696.58M
Debt
$532.96M
Equity
$701.99M
Working capital
$271.32M
Debt to equity
0.76
Current ratio
2.77
Quick ratio
1.59
Net debt/EBITDA
2.86
Margins
Efficiency
Dividend
EBITDA margin
16.9%
Gross margin
44.7%
Net margin
6.9%
Operating margin
11.5%
Return on assets
4.8%
Return on equity
9.2%
Return on invested capital
12.3%
Return on capital employed
8.2%
Return on sales
11.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NOVT stock price
How has the Novanta stock price performed over time
Intraday
-0.26%
1 week
2.82%
1 month
-1.2%
1 year
34.87%
YTD
4.96%
QTD
-1.2%
Financial performance
How have Novanta's revenue and profit performed over time
Revenue
$899.85M
Gross profit
$402.25M
Operating income
$103.31M
Net income
$62.17M
Gross margin
44.7%
Net margin
6.9%
Novanta's net margin has decreased by 20% YoY and by 12% from the previous quarter
The net income is down by 19% YoY and by 10% from the previous quarter
Novanta's operating margin has decreased by 10% YoY and by 7% QoQ
NOVT's operating income is down by 9% year-on-year and by 6% since the previous quarter
Growth
What is Novanta's growth rate over time
Valuation
What is Novanta stock price valuation
P/E
102.18
P/B
9.04
P/S
7.06
EV/EBIT
66.49
EV/EBITDA
44.62
EV/Sales
7.54
The stock's P/E is 22% more than its last 4 quarters average of 83.9 and 19% more than its 5-year quarterly average of 86.3
The EPS has contracted by 20% YoY and by 10% from the previous quarter
The equity has increased by 12% YoY and by 3% from the previous quarter
The price to book (P/B) is 5% higher than the last 4 quarters average of 8.6
The stock's price to sales (P/S) is 9% more than its 5-year quarterly average of 6.5 and 9% more than its last 4 quarters average of 6.5
Efficiency
How efficient is Novanta business performance
The ROE has contracted by 30% YoY and by 13% from the previous quarter
The company's return on assets fell by 24% YoY and by 13% QoQ
The ROS has contracted by 12% YoY and by 7% from the previous quarter
The ROIC is down by 12% year-on-year and by 8% since the previous quarter
Dividends
What is NOVT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NOVT.
Financial health
How did Novanta financials performed over time
The total assets is 101% more than the total liabilities
Novanta's total liabilities has increased by 15% YoY but it has decreased by 4.4% QoQ
The total assets has grown by 13% YoY
Novanta's debt is 24% less than its equity
Novanta's debt has increased by 17% YoY but it has decreased by 6% from the previous quarter
The equity has increased by 12% YoY and by 3% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.